Dongdong Jian

No. 79 Qingchun Road
Hangzhou, 310003, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Hepatic ChREBP Drives Cardiac Remodeling via ApoM Nontranscriptional Repression.

Hepatic ChREBP Drives Cardiac Remodeling via ApoM Nontranscriptional Repression.

Journal: Circulation research

Published: August 26, 2026

Two birds with one stone: Targeting METTL3 ameliorates doxorubicin-induced endothelial premature senescence and atherosclerosis while potentiating its antitumor efficacy.

Two birds with one stone: Targeting METTL3 ameliorates doxorubicin-induced endothelial premature senescence and atherosclerosis while potentiating its antitumor efficacy.

Journal: Free radical biology & medicine

Published: March 12, 2026

Single-lumen microcatheter based reversed wire technique (RWT) in the treatment of extremely angled coronary bifurcation lesions.

Single-lumen microcatheter based reversed wire technique (RWT) in the treatment of extremely angled coronary bifurcation lesions.

Journal: Cardiovascular intervention and therapeutics

Published: November 12, 2025

Modified langendorff-free method for isolating cardiomyocytes and non-cardiomyocytes from adult mice.

Modified langendorff-free method for isolating cardiomyocytes and non-cardiomyocytes from adult mice.

Journal: BMC biotechnology

Published: November 05, 2025

YTHDC1 Orchestrates Telomerase Assembly via Scaffold-Mediated TERT-TERC Interaction.

YTHDC1 Orchestrates Telomerase Assembly via Scaffold-Mediated TERT-TERC Interaction.

Journal: Aging cell

Published: July 30, 2025

METTL3/RBM15 augments the stability of Kdm6b mRNA and promotes STAT1-mediated macrophage activation and atherosclerosis.

METTL3/RBM15 augments the stability of Kdm6b mRNA and promotes STAT1-mediated macrophage activation and atherosclerosis.

Journal: Experimental & molecular medicine

Published: March 15, 2025

Engineered probiotic ameliorates hyperlipidemia and atherosclerosis by secreting PCSK9 nanobodies and regulating gut microbiota.

Engineered probiotic ameliorates hyperlipidemia and atherosclerosis by secreting PCSK9 nanobodies and regulating gut microbiota.

Journal: Bioengineering & translational medicine

Published: November 29, 2024

Nsun2 controls cardiac homeostasis and hypertrophic response by regulating PRKACA expression.

Nsun2 controls cardiac homeostasis and hypertrophic response by regulating PRKACA expression.

Journal: Theranostics

Published: September 30, 2024

METTL3-Mediated m6A Modification of ISG15 mRNA Regulates Doxorubicin-Induced Endothelial Cell Apoptosis.

METTL3-Mediated m6A Modification of ISG15 mRNA Regulates Doxorubicin-Induced Endothelial Cell Apoptosis.

Journal: Journal of cellular and molecular medicine

Published: September 26, 2024

Targeting OGF/OGFR signal to mitigate doxorubicin-induced cardiotoxicity.

Targeting OGF/OGFR signal to mitigate doxorubicin-induced cardiotoxicity.

Journal: Free radical biology & medicine

Published: June 09, 2024

Corrigendum to "Monocyte-derived extracellular vesicles upon treated by palmitate promote endothelial migration and monocytes attachment to endothelial cells" [Biochem. Biophys. Res. Commun. 523(3) (2020) 685-691].

Corrigendum to "Monocyte-derived extracellular vesicles upon treated by palmitate promote endothelial migration and monocytes attachment to endothelial cells" [Biochem. Biophys. Res. Commun. 523(3) (2020) 685-691].

Journal: Biochemical and biophysical research communications

Published: December 06, 2023

An orally administered bacterial membrane protein nanodrug ameliorates doxorubicin cardiotoxicity through alleviating impaired intestinal barrier.

An orally administered bacterial membrane protein nanodrug ameliorates doxorubicin cardiotoxicity through alleviating impaired intestinal barrier.

Journal: Bioactive materials

Published: September 28, 2023

Showing 1-12 of 29

Last Updated: 09/26/2026